AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015331 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Beatriz Santos Lapa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 300…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Liga Portuguesa Contra o Cancro - Núcleo Regional do Centro, Sociedade Portuguesa de Hematologia.
Abstract (Originalsprache)
The non-homologous end joining pathway is vital for repairing DNA double-strand breaks (DSB), with DNA-dependent protein kinase (DNA-PK) playing a critical role. Altered DNA damage response (DDR) in chronic (CML) and acute myeloid leukemia (AML) offers potential therapeutic opportunities. We studied the therapeutic potential of AZD-7648 (DNA-PK inhibitor) in CML and AML cell lines. This study used two CML (K-562 and LAMA-84) and five AML (HEL, HL-60, KG-1, NB-4, and THP-1) cell lines. DDR gene mutations were obtained from the COSMIC database. The copy number and methylation profile were evaluated using MS-MLPA and DDR genes, and telomere length using qPCR. p53 protein expression was assessed using Western Blot, chromosomal damage through cytokinesis-block micronucleus assay, and γH2AX levels and DSB repair kinetics using flow cytometry. Cell density and viability were analyzed using trypan blue assay after treatment with AZD-7648 in concentrations ranging from 10 to 200 µM. Cell death, cell cycle distribution, and cell proliferation rate were assessed using flow cytometry. The cells displayed different DNA baseline damage, DDR gene expressions, mutations, genetic/epigenetic changes, and p53 expression. Only HEL cells displayed inefficient DSB repair. The LAMA-84, HEL, and KG-1 cells were the most sensitive to AZD-7648, whereas HL-60 and K-562 showed a lower effect on density and viability. Besides the reduction in cell proliferation, AZD-7648 induced apoptosis, cell cycle arrest, and DNA damage. In conclusion, these results suggest that AZD-7648 holds promise as a potential therapy for myeloid leukemias, however, with variations in drug sensitivity among tested cell lines, thus supporting further investigation to identify the specific factors influencing sensitivity to this DNA-PK inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
- Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
- Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.
- Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
- Institute of Biophysics, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
- Cytogenetics and Genomics Laboratory, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
ORCID-Profile: Beatriz Santos Lapa, Joana Jorge, Raquel Alves, Mafalda Laranjo, Maria Filomena Botelho, Ana Bela Sarmento-Ribeiro, Ana Cristina Gonçalves
Förderung
- Fundação para a Ciência e Tecnologia
- Liga Portuguesa Contra o Cancro - Núcleo Regional do Centro
- Sociedade Portuguesa de Hematologia
- CIMAGO—Center of Investigation on Environment, Genetics, and Oncobiology, Faculty of Medicine, University of Coimbra, Portugal, by Sociedade Portuguesa de Hema…
- COMPETE-FEDER
- Centre for Innovative Biomedicine and Biotechnology (CIBB) and the Institute for Clinical and Biomedical Research (iCBR) are supported by the Foundation for Sc…
- FCT
Zitieren
APA
Lapa, B. S., Costa, M. I., Figueiredo, D., Jorge, J., Alves, R., Monteiro, A. R., Serambeque, B., Laranjo, M., Botelho, M. F., Carreira, I. M., Sarmento-Ribeiro, A. B., & Gonçalves, A. C. (2023). AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015331
Vancouver
Lapa BS, Costa MI, Figueiredo D, Jorge J, Alves R, Monteiro AR, et al. AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015331
BibTeX
@article{Lapa2023,
author = {Lapa, Beatriz Santos and Costa, Maria Inês and Figueiredo, Diana and Jorge, Joana and Alves, Raquel and Monteiro, Ana Raquel and Serambeque, Beatriz and Laranjo, Mafalda and Botelho, Maria Filomena and Carreira, Isabel Marques and Sarmento-Ribeiro, Ana Bela and Gonçalves, Ana Cristina},
title = {AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015331}
}
EUVIMED